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16
Discovery of new antibacterials can be facilitated by systematic identification of mutations that 17 suppress antibiotic resistance phenotypes, which can be used to establish specific and 18 prioritized lists of targets for drug development. Genetic suppressors of antibiotic resistance 19 can be identified by using ordered libraries of mutants (e.g., (1-4)). Growth differences among 20 mutants in response to antibiotics can be amplified by the competitive nature of the assays that 21 are based on pooled libraries (e.g., (5, 6)). Such comparative fitness assays may increase the 22 sensitivity of the antibiotic suppressor screens, but do so at the expense of very low specificity 23 (5). However, in the absence of reference lists of genes whose inactivation is expected to result 24 in increased antibiotic susceptibility, it is impossible to assess the sensitivity of such methods.
25
Furthermore, there may not be a discernable relationship between the relative fitness under 26 the antibiotic selective pressure and changes in the antibiotic's minimal inhibitory 27 concentration.
28
To independently evaluate these issues we designed a comparative fitness study that used a 29 laboratory strain of E. coli resistant to clinically relevant concentrations of the fluoroquinolone 30 antibiotic ciprofloxacin (7-10) and took advantage of existing information about the gene-31 modulators of the parental, or intrinsic, quinolone resistance (4, (11) (12) (13) (14) .
32
Using a double-controlled experimental design (Fig. 1) candidate genes whose insertions were likely to sensitize the resistant strain to the antibiotic. 52 We were able to construct 52 out of 57 in-frame deletions (17, 18) Cipro. The 52 deletion mutants could be divided into two classes (Table S2) (Fig.2B) . Resistance of rCip-8 was primarily modulated by the 73 activity of efflux pumps, followed by DNA repair, then regulators of the stress response and of 74 the genes whose products are involved in lipopolysaccharide biosynthesis.
75
Deletions of 5 genes: hofO, lpxM, miaA, yciS, and ygaH, whose activity has not been previously 76 associated with quinolone resistance, lowered MIC of the resistant strain 1.4-2.8 times (Table   77 1). Three of them increased the ciprofloxacin susceptibility of the parental as well as the 78 resistant strain, with a comparable reduction of the MIC (Table 1) . 
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